Interview: Paweł Mazur – East Area Director, Accord Healthcare, Poland
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Address: Al. Jerozolimskie 178
02-486 Warszawa
Polska
Tel: +48 22 53 59 700
Web: http://www.merck.pl/pl/index.html;jsessionid=9CED66F9573CAA393B136F45D38F55A1
Merck is a global pharmaceutical and chemical enterprise with around 40,000 employees in 64 countries. With the acquisition of Millipore in July 2010, a global leader in the life science tools market, pro forma revenues totaled around EUR 8.9 billion in 2009.
The Pharmaceuticals business sector comprises innovative prescription drugs as well as over-the-counter products. The Chemicals business sector offers specialty products for the electronics, printing, coatings, cosmetics, food, pharmaceutical and biotech industries.
The operational business is managed under the umbrella of Merck KGaA headquartered in Darmstadt (Germany). Around 30% of the company’s total capital is publicly traded, while the Merck family owns an interest of about 70% via the general partner E. Merck KG.
Merck is the world’s oldest pharmaceutical and chemical company – its roots date back to 1668.
Merck Sp. z o.o. is the Polish sales organization of the global Merck Group of Darmstadt, Germany. It has been supplying the Polish market with high-quality pharmaceutical and chemical products since 1992.
Major products – Pharma Therapeutic areas: Cardiovascular diseases, Endocrinology (thyroid disorders and diabetes), Neurodegenerative disorders (multiple sclerosis), Fertility, Psoriasis
Major products – Chemicals Effect pigments for the printing, plastics, coating and cosmetics industries; innovative products for all phases of drug manufacturing, active ingredients for decorative and personal care cosmetics, laboratory products
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Krzysztof Popławski, general manager of Baxter Poland, discusses the Baxter Education Center, the largest educational program for a European affiliate, and its role in raising the awareness within the Polish…
Hubert Niemyjski, country manager of Coloplast Poland and the Baltics, highlights the large differences between the market landscape of the company’s three pillars; ostomy, wound and continence care. Additionally, he…
Olympus is internationally well-regarded as being a quality camera provider and continues to provide developed countries across the globe with high-tech medical devices from endoscopes to imagery solutions. Tomasz Mrzygłód,…
Paweł Migdalski, CEO at Siemens Healthineers Poland, discusses the innovations they are bringing to the market and how they are building on the success of the Siemens Healthineers Academy. Furthermore,…
Tomasz Dzitko, founder and CEO of Delfarma, Poland’s leading parallel importer, gives an overview of the sector in Poland and its impact on the healthcare ecosystem, as well as the…
Piotr Steczniewski, president of Profarm PS – a successful wholesale family business – since 2012, shares how the company has managed to thrive over the years through constant adaptation to…
Łukasz Korybalski, regional manager of Becton Dickinson (BD) Central Eastern Europe, discusses the rising significance of the region as the company continues to grow and the strategic importance of Poland,…
Marzena Kulis, managing director of Johnson & Johnson Medical Devices CEE, highlights the importance of the region and Poland within J&J Medical Devices, and the impact of increasing healthcare expenditures…
Despite the global R&D excitement around oncology, cardiovascular death still remains the world’s largest killer, and according to OECD data, accounts for roughly a third of all mortalities. This trend…
Cezary Kilczewski, president and founder of Medicofarma, a Polish CMO, discusses the company’s recent upgrades to double production capacity and the move into R&D operations as well as the dynamics…
Andrzej Schonert, CEO of Synoptis Industrial, discusses the intricacies of the Polish market and the requirement to move into niche areas, mainly in Rx, to concentrate their pharmaceutical offering to…
See our Cookie Privacy Policy Here